Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy

Conclusions: SU/SO with DC-CIK could significantly prolong the median PFS, improve the 3-year OS rate, prolong the 3-year OS. It is likely to be a new approach for mRCC after radical nephrectomy.

Source: Journal of Cancer Research and Therapeutics - June 29, 2018 Category: Cancer & Oncology Authors: Hai-Xing Mai Guo-Hui Mei Fei-Long Zhao Bo-Tao Li Yong-Yong Tang Bin Zhang Xiao-Jie Xu Li-Jun Chen Source Type: research